T. Eisen
Royal Marsden Hospital
Downs Road
Surrey SMT 5PT
UK
Name/email consistency: high
- Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Eisen, T., Ahmad, T., Flaherty, K.T., Gore, M., Kaye, S., Marais, R., Gibbens, I., Hackett, S., James, M., Schuchter, L.M., Nathanson, K.L., Xia, C., Simantov, R., Schwartz, B., Poulin-Costello, M., O'Dwyer, P.J., Ratain, M.J. Br. J. Cancer (2006)